Ivonescimab Oncology Clinical Trials
1,600+ Patients Treated Across 19 Clinical Trials
Summit License Territories: United States, Canada, Europe and Japan
Akeso License Territories: Rest of World
All Akeso ivonescimab clinical trials are being conducted in China and/or Australia and are fully sponsored and managed by Akeso.
Learn more about our partnership with Akeso, Inc. here.
Filter
Summit Sponsored Ivonescimab Trials: Ivonescimab is currently being investigated in global Phase III clinical trials. Phase I and II were completed by our partner Akeso. This pipeline reflects clinical trials that have been announced.
![](https://www.smmttx.com/wp-content/uploads/2023/11/akeso-logo-100.png)
Akeso Sponsored Ivonescimab Trials
All Akeso ivonescimab clinical trials are being conducted in China and/or Australia and are fully sponsored and managed by Akeso.
Ivonescimab is an investigational therapy that is not approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).